Acute Respiratory Failure Clinical Trial
Official title:
Standardized Rehabilitation for ICU Patients With Acute Respiratory Failure
NCT number | NCT00976833 |
Other study ID # | IRB00007879 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | October 2009 |
Est. completion date | June 2015 |
Verified date | August 2018 |
Source | Wake Forest University Health Sciences |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Acute Respiratory Failure (ARF) requiring mechanical ventilation affects 1.1 million of the
4.4 million people admitted to United States Intensive Care Units (ICU) every year. Patients
with ARF have an average ICU and hospital length of stay (LOS) of 8 and 15 days,
respectively, with median hospital costs greater than $30,000 United States. Patients with
ARF experience deconditioning, muscle weakness, joint contractures, dyspnea, depression, and
reduced health-related quality of life, all of which may contribute to prolonged
hospitalization and increased costs. Mechanistically, it is understood that patients with ARF
demonstrate acute inflammation which may contribute to the above cited problems. While the
investigators' research and that of others has shown that rehabilitation therapy can increase
functional outcomes while lowering biomarkers of inflammation in the frail aged and other
clinical populations, it is not known whether such rehabilitation therapy can result in
improved functional capacity and functional performance and reduce inflammation in ARF
patients. There is previous evidence for the feasibility and safety of rehabilitation therapy
in ARF patients. Therefore, the investigators propose a two-arm, randomized trial in 326
patients with ARF to compare Standardized Rehabilitation Therapy initiated in the ICU and
administered throughout the hospitalization versus usual care (control). Standardized
Rehabilitation Therapy will consist of: passive range of motion, physical therapy and
progressive resistance exercise (strength training). The regimen will be administered 7
days/week by a Mobility Team consisting of a critical care nurse, physical therapist and
nursing assistant.
The investigators will determine whether standardized rehabilitation therapy will reduce
hospital LOS, improve functional capacity and performance, improve quality of life, reduce
inflammation and reduce hospital costs as compared to usual care.
This study's primary objective is to determine whether standardized rehabilitation therapy
will decrease hospital length of stay.
Hypothesis: Compared to usual care, standardized rehabilitation therapy will reduce hospital
length of stay for patients with Acute Respiratory Failure.
Status | Completed |
Enrollment | 300 |
Est. completion date | June 2015 |
Est. primary completion date | October 2014 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Age = 18 years - Mechanically ventilated via an Endotracheal tube or Bipap - Lung Injury Exclusion Criteria: - Previously enrolled in TARGET STUDY - Inability to walk without assistance prior to acute ICU illness (use of a cane or walker not exclusion) - Cognitive impairment prior to acute ICU illness (non-verbal) - Acute stroke - Body mass index (BMI) > 50 - Neuromuscular disease that could impair weaning - Hip fracture, unstable cervical spine or pathological fracture - Mechanically ventilated > 80 hours - Current hospitalization or transferring hospital stay > 7 days - Ineligible cancer treatment within the last 6 month - Moribund - Do Not Resuscitate(DNR)/Do Not Intubate(DNI) on admission - Other Research Study |
Country | Name | City | State |
---|---|---|---|
United States | Wake Forest University Health Sciences | Winston-Salem | North Carolina |
Lead Sponsor | Collaborator |
---|---|
Wake Forest University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | To determine whether standardized rehabilitation therapy will decrease hospital length of stay. | 5 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05144633 -
Blue Protocol and Eko Artificial Intelligence Are Best (BEA-BEST)
|
||
Completed |
NCT04534569 -
Expert Panel Statement for the Respiratory Management of COVID-19 Related Acute Respiratory Failure (C-ARF)
|
||
Recruiting |
NCT03021902 -
Nutrition and Exercise in Critical Illness
|
Phase 2 | |
Completed |
NCT02902146 -
Bougie Use in Emergency Airway Management
|
N/A | |
Completed |
NCT02901158 -
Esophageal Manometry in Mechanically Ventilated Patients
|
||
Completed |
NCT02236559 -
High Flow Therapy for the Treatment of Respiratory Failure in the ED
|
N/A | |
Recruiting |
NCT02056093 -
Comparison of Proportional Assist Ventilation And Neurally Adjusted Ventilator Assist
|
N/A | |
Terminated |
NCT01083277 -
Variable Ventilation During Acute Respiratory Failure
|
N/A | |
Not yet recruiting |
NCT01668368 -
Goal Directed Mechanical Ventilation Aimed at Optimal Lung Compliance
|
N/A | |
Completed |
NCT01462279 -
Effect of Thiamine on Oxygen Utilization (VO2) in Critical Illness
|
N/A | |
Completed |
NCT01114022 -
Prevention Inhalation of Bacterial by Using Endotracheal Tube Balloon Polyvinyl Chloride or Polyurethane
|
N/A | |
Active, not recruiting |
NCT01058421 -
Treatment of Critical Illness Polyneuromyopathy
|
Phase 2 | |
Completed |
NCT00252616 -
Timing of Target Enteral Feeding in the Mechanically Ventilated Patient
|
Phase 2/Phase 3 | |
Recruiting |
NCT04098094 -
Outcomes of RV Dysfunction in Acute Exacerbation of Chronic Respiratory Diseases
|
||
Recruiting |
NCT06051292 -
Decremental Esophageal Catheter Filling Volume Titration For Transpulmonary Pressure Measurement
|
N/A | |
Completed |
NCT04601090 -
Survival Rates and Longterm Outcomes After COVID-19
|
||
Recruiting |
NCT05423301 -
Global Physiotherapy in ICU Patients With High Risk Extubation Failure
|
N/A | |
Completed |
NCT02447692 -
Proportional Assist Ventilation for Minimizing the Duration of Mechanical Ventilation: The PROMIZING Study
|
N/A | |
Completed |
NCT04016480 -
HFNC During Bronchoscopy for Bronchoalveolar Lavage
|
N/A | |
Completed |
NCT04507425 -
High Flow Nasal Cannula With Noninvasive Ventilation
|
N/A |